The novel approach of the medication represents a significant advance in the management of the condition. Unlike existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide050031.blogsmine.com/42341627/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment